Sentinel API Group is reshoring US domestic active pharmaceutical manufacturing platform focused on essential high-volume generic medicines. No R&D, No clinical trial tail, and DMF ready day one. Policy-backed, Grant leveraged, and capital staged for scale.
Fundraise Details
This section is only visible to registered investors. Log in or register as an accredited investor to view.